Skip to main content
Toggle navigation
Search
Home
164 Views
Facebook
Tweet
Print
Plenary
Session: Plenary V: The Role of HLA Matching in Allogenetic Cellular Therapies
The Role of HLA and Histocompatibility for Donor Selection in Emerging Allo Cellular Therapies
Friday, October 25, 2024
9:30 AM - 10:00 AM
US PDT
Location: Marquis Center
Speaker(s)
Colleen Delaney, MD, MSc
Deverra Therapeutics
Learning Objectives:
Gain an understanding of current advances in allogeneic cellular therapies and related histocompatibility factors
Identify opportunities for histocompatibility testing to support cellular therapies and review some case studies.
The role of the lab in supporting and advising on histocompatibility considerations for cellular therapies